Medpedia

Edward Mc Sweegan

Program Officer, NIH

Crofton, MD

Professional summary

Edward McSweegan, Ph.D., is a program officer at NIAID. He graduated from Boston College in 1978 (B.S.) and has degrees in microbiology from the University of New Hampshire (M.S.) and the University of Rhode Island (Ph.D.). He was a National Research Council Associate from 1984 to 1986 and did postdoctoral research at the Naval Medical Research Institute in Bethesda, Maryland. Dr. McSweegan served as an American Association for the Advancement of Science Diplomacy Fellow in the U.S. State Department from 1986 to 1988. After moving to the NIH, he continued to work on international health and science projects in Egypt, Israel, India, and Russia. Currently, he manages NIAID’s bilateral program with India, the Indo–U.S. Vaccine Action Program, and represents NIAID in the DHHS Biotechnology Engagement Program (BTEP) with Russia and related countries. He is a member of AAAS, ASM and IOM’s Forum on Microbial Threats.

Education

Universities

University of Rhode Island

Ph.D., Microbiology
1981 to 1984

University of New Hampshire

M.S., Microbiology
1978 to 1980

Boston College

B.S., Biology
1976 to 1978

Postgraduate Training

U.S. State Department

1986 to 1988
AAAS Diplomacy Fellow

Naval Medical Research Institute

1984 to 1986
National Research Council Associateship

Certifications

Infectious Disease Epidemiology

2005
23rd Annual Graduate Summer Institute of Epidemiology and Biostatistics

Epidemiology in Action

2004
Rollins School of Public Health at Emory University and the Centers for Disease Control and Prevention

Honors and Awards

Grand Prize, Fiction

Maryland Writer’s Association
2002

“Visions of the Future” Essay Winner

Science magazine
1999

U.S.-Egypt Cooperative Health Program Recognition of Contribution

Govt. of Egypt
1995

Director’s Award

NIAID
1992

Tribute of Appreciation

U.S. Department of State
1987

Science, Engineering, and Diplomacy Fellow

AAAS
1986

Outstanding Research Associate

NMRI
1985

Publications

Articles

"Lyme disease and the politics of public advocacy."

Clinical infectious diseases : an official publication of the Infectious Diseases Soc
Vol. 47 - 2008;
PubMed ID: 19025374

"Anti-tumor necrosis factor-alpha treatment for Lyme borreliosis."

The Journal of infectious diseases
Vol. 196 - 2008;
PubMed ID: 18190271

"A critical appraisal of "chronic Lyme disease"."

The New England journal of medicine
Vol. 357 - 2007;
PubMed ID: 17914043

"Lyme vaccine demonized by advocacy groups."

Nature
Vol. 440 - 2006;
PubMed ID: 16541048

"The Lyme vaccine: a cautionary tale."

Epidemiology and infection
Vol. 135 - 2006;
PubMed ID: 17064458

"Review of John Kelly’s The Great Mortality: An Intimate History of the Black Death, the Most Devastating Plague of All Time"

JAMA
Vol. 293 - 2005; 1524

"Biodefence funds have tight strings attached."

Nature
Vol. 427 - 2004;
PubMed ID: 14749802

"Review of Vincent J. Cirillo’s Bullets and Bacilli: the Spanish-American War and Military Medicine"

JAMA
Vol. 292 - 4 2004; 506-507

"Anthrax and the etiology of the English sweating sickness."

Medical hypotheses
Vol. 62 - 2004;
PubMed ID: 14729023

"Lack of trained security staff delays US visas."

Nature
Vol. 423 - 2003;
PubMed ID: 12736652

"Screening foreign scholars."

Science (New York, N.Y.)
Vol. 297 - 2002;
PubMed ID: 12162320

"Lyme disease (LD) is a potential health concern for school-age children."

The Journal of school nursing : the official publication of the National Association
Vol. 17 - 2002;
PubMed ID: 11885449

"Portugal: a case history in S&T cooperation."

Science (New York, N.Y.)
Vol. 291 - 2001;
PubMed ID: 11286271

"Review of Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response"

JAMA
Vol. 283 - 2000; 2035-2036

"Submitting Electronic Biologics Applications to CBER."

Drug Information J.
Vol. 33 - 1999; 1-15

"Infectious diseases and mental illness: is there a link?"

Emerging infectious diseases
Vol. 4 - 1998;
PubMed ID: 9452407

"Submitting Electronic Clinical and Statistical Data to the"

Applied Clinical Trials
Vol. 8 - 1998; 38-47

"Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors."

JAMA : the journal of the American Medical Association
Vol. 275 - 1996;
PubMed ID: 8627968

"Strategies to prevent and control the emergence and spread of anti-microbial-resistant microorganisms in hospitals: A challenge to hospital leadership."

JAMA
Vol. 275 - 1996; 234-240

"The infectious diseases impact statement: a mechanism for addressing emerging diseases."

Emerging infectious diseases
Vol. 2 - 1996;
PubMed ID: 8903209

"Bacterial endotoxins and pathogenesis of gram negative infections: current status and future directions."

J. Endotoxin Res.
Vol. 1 - 1994; 71-83.

"Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells."

Infection and immunity
Vol. 55 - 1987;
PubMed ID: 3570473

"Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucus substrates."

Infect. Immun.
Vol. 53 - 1986; 141-48

"Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K12 (K88 ab)."

Infect. Immun.
Vol. 52 - 1985; 18-25

"Adhesion of enterotoxigenic Escherichia coli to immobilized intestinal mucosal preparations: a model for adhesion to mucosal surface components."

J. Microbiol. Methods.
Vol. 2 - 27 1984; 27-39

Disclosures

Edward Mc Sweegan has nothing to disclose

Edward Mc Sweegan
Leave a message on his Wall

Tokens of Appreciation

A Token of Appreciation is a way of acknowledging another member for their contributions to Medpedia. You have 5 Tokens to give per week.

Groups and Organizations

Medpedia Editors Medpedia Editors

» See All

Editor Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Professional Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ